Supplements and Age-Related Eye Conditions. The Beaver Dam Eye Study

Ophthalmology

Volumn 115, Issue 7, 2008, Pages 1203-1208

  Klein, Barbara E K ^a   Knudtson, Michael D ^a   Lee, Kristine E ^a   Reinke, Jennifer O ^a   Danforth, Lorraine G ^a   Wealti, Angela M ^a   Moore, Emily ^a   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; MULTIVITAMIN; RETINOL; VITAMIN D; ZINC;

ADULT; AGED; AGING; ARTICLE; CATARACT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; CATARACT; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PHOTOGRAPHY; PLANT PREPARATIONS; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; TRACE ELEMENTS; VITAMINS; WISCONSIN;

EID: 45849152116     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.09.011     Document Type: Article

References (47)

1. Kessler R.C., Davis R.B., Foster D.F., et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135 (2001) 262-268
2. Ervin R.B., Wright J.D., and Reed-Gillette D. Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988-94. Adv Data 349 (2004) 1-7
3. Tindle H.A., Davis R.B., Phillips R.S., and Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11 (2005) 42-49
4. NIH State-of-the-Science Panel. National Institutes of Health state-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention. Ann Intern Med 145 (2006) 364-371
5. Radimer K., Bindewald B., Hughes J., et al. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160 (2004) 339-349
6. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
7. Radimer K.L., Subar A.F., and Thompson F.E. Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. J Am Diet Assoc 100 (2000) 447-454
8. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287 (2002) 337-344
9. Ni H., Simile C., and Hardy A.M. Utilization of complementary and alternative medicine by United States adults: results from the 1999 National Health Interview Survey. Med Care 40 (2002) 353-358
10. Rafferty A.P., McGee H.B., Miller C.E., and Reyes M. Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 92 (2002) 1598-1600
11. Schaffer D.M., Gordon N.P., Jensen C.D., and Avins A.L. Nonvitamin, nonmineral supplement use over a 12-month period by adult members of a large health maintenance organization. J Am Diet Assoc 103 (2003) 1500-1505
12. Bent S., and Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 116 (2004) 478-485
13. Barnes P.M., Powell-Griner E., McFann K., and Nahin R.L. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343 (2004) 1-19
14. Yu S.M., Ghandour R.M., and Huang Z.J. Herbal supplement use among US women, 2000. J Am Med Womens Assoc 59 1 (2004) 17-24
15. Wheaton A.G., Blanck H.M., Gizlice Z., and Reyes M. Medicinal herb use in a population-based survey of adults: prevalence and frequency of use, reasons for use, and use among their children. Ann Epidemiol 15 (2005) 678-685
16. Kronenberg F., Cushman L.F., Wade C.M., et al. Race/ethnicity and women's use of complementary and alternative medicine in the United States: results of a national survey. Am J Public Health 96 (2006) 1236-1242
17. Druss B.G., and Rosenheck R.A. Association between use of unconventional therapies and conventional medical services. JAMA 282 (1999) 651-656
18. Reinert A., Rohrmann S., Becker N., and Linseisen J. Lifestyle and diet in people using dietary supplements: a German cohort study. Eur J Nutr 46 (2007) 165-173
19. Knudtson MD, Klein R, Lee KE, et al. A longitudinal study of non-vitamin, non-mineral supplement use: prevalence, associations, and survival in an aging population. Ann Epidemiol. In press.
20. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119 (2001) 1439-1452
21. van Leeuwen R., Boekhoorn S., Vingerling J.R., et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294 (2005) 3101-3107
22. Vu H.T., Robman L., Hodge A., et al. Lutein and zeaxanthin and the risk of cataract: the Melbourne Visual Impairment Project. Invest Ophthalmol Vis Sci 47 (2006) 3783-3786
23. Jacques P.F., Chylack Jr. L.T., Hankinson S.E., et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 119 (2001) 1009-1019
24. Christen W.G., Glynn R.J., and Hennekens C.H. Antioxidants and age-related eye disease: current and future perspectives. Ann Epidemiol 6 (1996) 60-66
25. West A.L., Oren G.A., and Moroi S.E. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol 141 (2006) 157-166
26. Ritch R. Complementary therapy for the treatment of glaucoma: a perspective. Ophthalmol Clin North Am 18 (2005) 597-609
27. Head K.A. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev 6 (2001) 141-166
28. Evans J.R. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev 3 (1999) CD001775
29. Klein R., Klein B.E., Linton K.L., and De Mets D.L. The Beaver Dam Eye Study: visual acuity. Ophthalmology 98 (1991) 1310-1315
30. Klein R., Klein B.E., and Lee K.E. Changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology 103 (1996) 1169-1178
31. Klein R., Klein B.E., Lee K.E., et al. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology 108 (2001) 1757-1766
32. Klein R., Klein B.E., Lee K.E., et al. Changes in visual acuity in a population over a 15-year period. The Beaver Dam Eye Study. Am J Ophthalmol 142 (2006) 539-549
33. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 98 (1991) 1128-1134
34. Klein B.E., Klein R., Linton K.L., et al. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 97 (1990) 1428-1433
35. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
36. Klein R., Klein B.E., Jensen S.C., and Meuer S.M. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
37. Klein B.E., Klein R., Sponsel W.E., et al. Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 1499-1504
38. U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. Pub L No. 103-417, 108 Stat 4325 (1994). http://www.fda.gov/opacom/laws/dshea.html Accessed September 12, 2007
39. Taylor D.A. Botanical supplements: weeding out the health risks. Environ Health Perspect 112 (2004) A750-A753
40. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 279 (1998) 1548-1553
41. Chiu C.J., and Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res 84 (2007) 229-245
42. Fraunfelder F.W. Ocular side effects associated with dietary supplements and herbal medicines. Drugs Today (Barc) 41 (2005) 537-545
43. Fraunfelder F.W., and Fraunfelder F.T. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology 111 (2004) 1275-1279
44. Bressler N.M. Cystoid macular edema from niacin typically is not accompanied by fluorescein leakage on angiography. [letter]. Am J Ophthalmol 139 (2005) 951
45. Bjelakovic G., Nikolova D., Gluud L.L., et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
46. Donaldson M.J., and Pulido J.S. Treatment of nonexudative (dry) age-related macular degeneration. Curr Opin Ophthalmol 17 (2006) 267-274
47. Bast A., and Haenen G.R. The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol 11 (2002) 251-258